In that study, researchers reported that SDF1 (alias, CXCL12) conferred significantly improved event-free survival among patients with symptomatic CAD, even after controlling for clinical covariates (Rath et al., 2016). The gene discussed is CXCL12; the disease is coronary artery disorder.